| scholarly article | Q13442814 |
| P50 | author | Andrea Ilari | Q43021315 |
| Gianni Colotti | Q43433196 | ||
| P2093 | author name string | Alberto Boffi | |
| Annarita Fiorillo | |||
| Paola Baiocco | |||
| Elena Poser | |||
| Francesco Di Chiaro | |||
| P2860 | cites work | Molecular basis of glutathione synthetase deficiency and a rare gene permutation event | Q22009992 |
| Combining climatic projections and dispersal ability: a method for estimating the responses of sandfly vector species to climate change | Q24290796 | ||
| Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design | Q24616801 | ||
| Dissecting the essentiality of the bifunctional trypanothione synthetase-amidase in Trypanosoma brucei using chemical and genetic methods | Q24649110 | ||
| Catalytic cycle of human glutathione reductase near 1 A resolution | Q24650824 | ||
| Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities | Q24655332 | ||
| Chemical validation of trypanothione synthetase: a potential drug target for human trypanosomiasis | Q24657204 | ||
| Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy | Q24675194 | ||
| The structure of reduced tryparedoxin peroxidase reveals a decamer and insight into reactivity of 2Cys-peroxiredoxins | Q27625327 | ||
| Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling | Q27641054 | ||
| Structural and mechanistic insights into type II trypanosomatid tryparedoxin-dependent peroxidases | Q27650739 | ||
| Molecular basis of antimony treatment in leishmaniasis | Q27654300 | ||
| Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation | Q27670615 | ||
| A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition | Q27671675 | ||
| The Crystal Structures of the Tryparedoxin-Tryparedoxin Peroxidase Couple Unveil the Structural Determinants of Leishmania Detoxification Pathway | Q27671738 | ||
| Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography | Q27671819 | ||
| Synthesis and characterization of a pyridine-2-thiol N-oxide gold(I) complex with potent antiproliferative effect against Trypanosoma cruzi and Leishmania sp. insight into its mechanism of action | Q39861737 | ||
| Depletion of the thioredoxin homologue tryparedoxin impairs antioxidative defence in African trypanosomes | Q40220444 | ||
| QSAR study on the contribution of log P and E(s) to the in vitro antiprotozoal activity of glutathione derivatives | Q40784109 | ||
| Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages. | Q42123859 | ||
| Education is key to controlling visceral leishmaniasis | Q42942572 | ||
| ATP-dependent ligases in trypanothione biosynthesis--kinetics of catalysis and inhibition by phosphinic acid pseudopeptides | Q43106044 | ||
| Synthesis, inhibition potency, binding mode, and antiprotozoal activities of fluorescent inhibitors of trypanothione reductase based on mepacrine-conjugated diaryl sulfide scaffolds | Q43256895 | ||
| Specific peptide inhibitors of trypanothione reductase with backbone structures unrelated to that of substrate: potential rational drug design lead frameworks | Q43594914 | ||
| The cytosolic tryparedoxin of Leishmania infantum is essential for parasite survival | Q44251035 | ||
| Role of peroxidoxins in Leishmania chagasi survival. Evidence of an enzymatic defense against nitrosative stress | Q44279233 | ||
| 1-Azakenpaullone is a selective inhibitor of glycogen synthase kinase-3 beta | Q44708058 | ||
| Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani. | Q45909806 | ||
| Diaryl sulfide-based inhibitors of trypanothione reductase: inhibition potency, revised binding mode and antiprotozoal activities | Q46309139 | ||
| Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis | Q46610163 | ||
| In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum | Q46751240 | ||
| Evidence that the High Incidence of Treatment Failures in Indian Kala‐Azar Is Due to the Emergence of Antimony‐Resistant Strains ofLeishmania donovani | Q56781882 | ||
| Improved Inhibitors of Trypanothione Reductase by Combination of Motifs: Synthesis, Inhibitory Potency, Binding Mode, and Antiprotozoal Activities | Q58848500 | ||
| Rational design of selective ligands for trypanothione reductase fromtrypanosoma cruzStructural effects on the inhibition by dibenzazepines based on imipramine | Q58850207 | ||
| Structural insights into the peroxidase activity and inactivation of human peroxiredoxin 4 | Q27673881 | ||
| Crystal Structure of Reduced and of Oxidized Peroxiredoxin IV Enzyme Reveals a Stable Oxidized Decamer and a Non-disulfide-bonded Intermediate in the Catalytic Cycle | Q27675001 | ||
| Inhibitory Effect of Silver Nanoparticles on Trypanothione Reductase Activity and Leishmania infantum Proliferation | Q27684102 | ||
| Inhibition of Leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by X-ray crystallography | Q27684748 | ||
| Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: substrate crystal structures at 2 A resolution | Q27700157 | ||
| Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress | Q28144631 | ||
| The increase in risk factors for leishmaniasis worldwide | Q28211413 | ||
| Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism | Q28275518 | ||
| Clinical pharmacology of gold | Q28282618 | ||
| Occurrence of Leishmania infantum cutaneous leishmaniasis in central Tunisia | Q28287027 | ||
| Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids | Q28306157 | ||
| Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites | Q28468760 | ||
| Molecular dynamics reveal binding mode of glutathionylspermidine by trypanothione synthetase | Q28486718 | ||
| Drug resistance in leishmaniasis | Q29616242 | ||
| Comparative genomics of trypanosomatid parasitic protozoa | Q29617953 | ||
| Structural classification of proteins: new superfamilies | Q30425123 | ||
| Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate | Q30802015 | ||
| Investigation of trypanothione reductase as a drug target in Trypanosoma brucei | Q30897674 | ||
| Kinetics and Redox-Sensitive Oligomerisation Reveal Negative Subunit Cooperativity in Tryparedoxin Peroxidase of Trypanosoma brucei brucei | Q30932104 | ||
| Spread of vector-borne diseases and neglect of Leishmaniasis, Europe | Q31161304 | ||
| 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. | Q31917058 | ||
| The evolution and diversity of kinetoplastid flagellates. | Q33234948 | ||
| Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis | Q33406583 | ||
| Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors | Q34097455 | ||
| Target assessment for antiparasitic drug discovery | Q34301994 | ||
| Chemotherapy of leishmaniasis | Q34541670 | ||
| The Role of Glutathione Peroxidases in Trypanosomatids | Q35129255 | ||
| Dual binding sites for translocation catalysis by Escherichia coli glutathionylspermidine synthetase | Q35222226 | ||
| Therapeutic switching in leishmania chemotherapy: a distinct approach towards unsatisfied treatment needs | Q35606296 | ||
| Re-emergence of visceral and cutaneous leishmaniasis in the Greek Island of Crete | Q35823833 | ||
| Polyamine metabolism in Leishmania: from arginine to trypanothione | Q37761657 | ||
| Targeting Trypanothione Metabolism in Trypanosomatid Human Parasites | Q37782110 | ||
| The trypanothione system and the opportunities it offers to create drugs for the neglected kinetoplast diseases | Q37881219 | ||
| Liposomal amphotericin B in drug-resistant visceral leishmaniasis | Q38963223 | ||
| Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei | Q39191259 | ||
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1861-1875 | |
| P577 | publication date | 2013-10-01 | |
| P1433 | published in | Future Medicinal Chemistry | Q19280078 |
| P1476 | title | Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs | |
| P478 | volume | 5 |
| Q37546985 | Arginase Is Essential for Survival of Leishmania donovani Promastigotes but Not Intracellular Amastigotes |
| Q39329032 | Foreword. Trypanosomatid disease drug discovery and target identification |
| Q64249811 | Future Prospects in the Treatment of Parasitic Diseases: 2-Amino-1,3,4-Thiadiazoles in Leishmaniasis |
| Q92864476 | GDP-Mannose Pyrophosphorylase: A Biologically Validated Target for Drug Development Against Leishmaniasis |
| Q60312595 | Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening |
| Q41627520 | Improved orthologous databases to ease protozoan targets inference |
| Q36252376 | Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives |
| Q93126792 | Leishmania mexicana Trypanothione Reductase Inhibitors: Computational and Biological Studies |
| Q96304575 | Leishmanicidal Potential of Hardwickiic Acid Isolated From Croton sylvaticus |
| Q36263511 | Multicomponent reaction-based synthesis and biological evaluation of tricyclic heterofused quinolines with multi-trypanosomatid activity |
| Q38891993 | Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents. |
| Q38783627 | Polyamine-trypanothione pathway: an update. |
| Q27011766 | Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis |
| Q27702048 | Structural insights into the novel inhibition mechanism of Trypanosoma cruzi spermidine synthase |
| Q40396694 | Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking |
Search more.